Thought Leadership

P2C Announces Partnership to Support Development for Sickle Cell Disease

Read more about P2C Announces Partnership to Support Development for Sickle Cell Disease

New York, NY, April 18, 2024 – Pathway to Cures (P2C) announced its collaborative partnership with Afimmune to support the development of Epeleuton as a potential therapeutic for Sickle Cell Disease (SCD).

Co-pay Accumulator Policies Hurt Patients. There’s a Simple Solution.

Read more about Co-pay Accumulator Policies Hurt Patients. There’s a Simple Solution.

This piece is a joint effort by Amy Niles, executive vice president at the PAN Foundation, and Kollet Koulianos, vice president of payer relations at the National Hemophilia Foundation.

Subscribe to Thought Leadership